Table 3

Variation in Daily Morphine Milligram Equivalent (MME) for Patients on Chronic Opioids by Patient, Clinician, and Clinic Characteristics

CharacteristicsNMedian Daily MME (IQR)Kruskal-Wallis P Value
Patient level
SexFemale59130.0 (15.0-51.4).06
Male31130.0 (15.9-60.0)
RaceAsian/Asian American613.7 (5.8-36.3)<.01
Black/African38930.0 (20.0-52.5)
American
White43530.0 (13.7-60.0)
Other2024.2 (11.3-59.6)
Declined5213.1 (5.7-30.7)
EthnicityHispanic1220.6 (5.8-49.4).08
Not Hispanic82030.0 (15.7-57.2)
Sleep apneaYes19430.0 (20.0-57.2).08
No70830.0 (15.0-55.5)
Depression or anxietyYes53731.5 (16.7-60.0)<.01
No36525.6 (15.0-48.3)
Substance use disorderYes11841.4 (22.5-82.5)<.01
No78430.0 (15.0-52.5)
Hepatic insufficiencyYes15338.9 (18.2-60.0).01
No74930.0 (15.0-53.7)
Renal insufficiencyYes17430.0 (20.0-60.0).03
No72830.0 (15.0-54.0)
Concurrent benzodiazepine prescriptionYes21631.0 (15.0-69.6).09
No68630.0 (15.0-51.1)
Clinician level
Degree typeMD15743.3 (19.1-67.7)<.01
DO1038.6 (26.3-57.9)
NP2118.4 (7.1-57.0)
PA75.1 (3.0-14.6)
Other120.0 (20.0-20.0)
Age<5013743.4 (18.2-61.7).24
≥504335.1 (14.0-56.5)
SexFemale11333.6 (11.2-53.2)<.01
Male8346.8 (25.1-69.7)
SpecialtyFamily medicine10318.2 (7.5-42.0)<.01
Internal medicine9351.0 (40.1-74.2)
Trainee or attending statusAttending13125.4 (9.2-56.5)<.01
Resident6552.5 (40.2-71.0)
Clinic level
TypeUrban, underserved861.6 (54.4-65.4).05
Suburban1026.1 (15.0-57.6)
Number of clinicians<5 clinicians525.1 (13.7-51.0).26
5+ clinicians1357.7 (28.3-64.1)
Training site?Residents268.3 (64.1-72.5).09
No residents1640.0 (22.1-61.6)